Cite
Gessler T, Ghofrani HA, Held M, et al. The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension. Pulm Circ. 2017;7(2):505-513doi: 10.1177/2045893217706691.
Gessler, T., Ghofrani, H. A., Held, M., Klose, H., Leuchte, H., Olschewski, H., Rosenkranz, S., Fels, L., Li, N., Ren, D., Kaiser, A., Schultze-Mosgau, M. H., Müllinger, B., Rohde, B., & Seeger, W. (2017). The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension. Pulmonary circulation, 7(2), 505-513. https://doi.org/10.1177/2045893217706691
Gessler, Tobias, et al. "The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension." Pulmonary circulation vol. 7,2 (2017): 505-513. doi: https://doi.org/10.1177/2045893217706691
Gessler T, Ghofrani HA, Held M, Klose H, Leuchte H, Olschewski H, Rosenkranz S, Fels L, Li N, Ren D, Kaiser A, Schultze-Mosgau MH, Müllinger B, Rohde B, Seeger W. The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension. Pulm Circ. 2017 Apr-Jun;7(2):505-513. doi: 10.1177/2045893217706691. Epub 2017 May 12. PMID: 28597762; PMCID: PMC5467944.
Copy
Download .nbib